MarketCap
Lixte Biotechnology Holdings LIXT
Facebook
X
Telegram
Lixte Biotechnology Holdings Langfristiger Schuldenstrom | LIXT
Langfristiger Schuldenstrom Jährlich Lixte Biotechnology Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 595 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 595 K | 595 K | 595 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M |  Canada |
 |
Precision BioSciences
DTIL
|
1.51 M | $ 9.47 | -2.17 % | $ 121 M |  USA |
 |
AIM ImmunoTech
AIM
|
250 K | $ 0.14 | -11.15 % | $ 227 K | USA |
 |
Ascendis Pharma A/S
ASND
|
14.2 M | $ 256.21 | -1.4 % | $ 15.5 B |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
1.92 M | $ 71.31 | 5.19 % | $ 1.43 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
711 K | $ 1.56 | 1.3 % | $ 48.7 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.31 | -0.76 % | $ 349 M |  Britain |
 |
Monopar Therapeutics
MNPR
|
90.6 K | $ 71.42 | -3.16 % | $ 529 M | USA |
 |
BridgeBio Pharma
BBIO
|
6.19 M | $ 78.67 | 0.95 % | $ 15.1 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
317 K | $ 7.53 | -1.38 % | $ 1.58 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
2.55 M | $ 3.68 | -2.39 % | $ 255 M | Britain |
 |
Coherus BioSciences
CHRS
|
1.83 M | $ 0.64 | -21.66 % | $ 75 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
294 K | $ 27.45 | 4.77 % | $ 3.49 B | USA |
 |
Cellectis S.A.
CLLS
|
7.7 M | $ 1.12 | -0.45 % | $ 112 M |  France |
 |
BeyondSpring
BYSI
|
320 K | $ 0.6 | -2.21 % | $ 24.7 M | USA |
 |
Alkermes plc
ALKS
|
6.75 M | $ 46.48 | 0.67 % | $ 7.66 B |  Irlanda |
 |
Altimmune
ALT
|
256 K | $ 1.94 | -8.51 % | $ 171 M | USA |
 |
Cardiff Oncology
CRDF
|
730 K | $ 0.79 | -0.77 % | $ 52.8 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
88.3 K | $ 0.5 | -5.43 % | $ 5.53 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 9.41 | -0.84 % | $ 258 M |  Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
7.29 M | $ 49.04 | -0.41 % | $ 6.56 B | USA |
 |
Atara Biotherapeutics
ATRA
|
1.03 M | $ 8.18 | -0.73 % | $ 103 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
1.07 M | $ 16.3 | -1.93 % | $ 2.19 B | Canada |
 |
Cullinan Management
CGEM
|
780 K | $ 11.34 | -3.32 % | $ 683 M | USA |
 |
BioNTech SE
BNTX
|
45 M | $ 87.2 | -0.36 % | $ 21.1 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
1.41 M | $ 24.47 | -0.97 % | $ 775 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
1.63 M | $ 3.95 | 12.07 % | $ 52.6 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
235 K | $ 1.21 | -11.68 % | $ 55.3 M | Israel |
 |
AnaptysBio
ANAB
|
2.16 M | $ 48.4 | 0.9 % | $ 1.4 B | USA |
 |
Assembly Biosciences
ASMB
|
569 K | $ 21.33 | -2.11 % | $ 239 M | USA |
 |
Adagene
ADAG
|
92.1 K | $ 2.02 | -4.95 % | $ 119 M |  China |
 |
Benitec Biopharma
BNTC
|
496 K | $ 9.31 | -5.67 % | $ 433 M | USA |
 |
Denali Therapeutics
DNLI
|
9.46 M | $ 19.85 | -2.36 % | $ 3.43 B | USA |
 |
Amarin Corporation plc
AMRN
|
2.15 M | $ 11.75 | 0.09 % | $ 4.88 B | Irlanda |
 |
ImmuCell Corporation
ICCC
|
85.5 K | $ 10.4 | 1.76 % | $ 93.9 M | USA |
 |
Editas Medicine
EDIT
|
6.03 M | $ 2.5 | -9.09 % | $ 222 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
18.4 M | $ 31.77 | 1.23 % | $ 1.84 B | USA |
 |
Cue Biopharma
CUE
|
1.91 M | $ 18.89 | -6.21 % | $ 1.79 B | USA |
 |
Equillium
EQ
|
363 K | $ 1.45 | -3.33 % | $ 83.1 M | USA |
 |
Black Diamond Therapeutics
BDTX
|
3.71 M | $ 1.6 | -14.05 % | $ 91 M | USA |
 |
Abeona Therapeutics
ABEO
|
864 K | $ 2.46 | -3.35 % | $ 130 M | USA |
 |
ACADIA Pharmaceuticals
ACAD
|
11.6 M | $ 18.13 | 9.85 % | $ 3.05 B | USA |
 |
Atossa Therapeutics
ATOS
|
18.1 K | $ 2.21 | 3.76 % | $ 19 M | USA |
 |
ADC Therapeutics SA
ADCT
|
538 K | $ 1.51 | -9.88 % | $ 192 M |  Schweiz |
 |
Harmony Biosciences Holdings
HRMY
|
1.07 M | $ 33.57 | -0.62 % | $ 1.93 B | USA |
 |
Ardelyx
ARDX
|
1.48 M | $ 3.0 | 2.39 % | $ 723 M | USA |
 |
Akebia Therapeutics
AKBA
|
3.55 M | $ 0.54 | 1.8 % | $ 139 M | USA |
 |
Alector
ALEC
|
9.06 M | $ 2.54 | 3.05 % | $ 262 M | USA |